116 related articles for article (PubMed ID: 11229654)
1. Hydrocortisone, prednisolone and dexamethasone act on Aspergillus fumigatus in vitro susceptibility to itraconazole.
Ramondenc I; Pinel C; Parat S; Ambroise-Thomas P; Grillot R
Microbios; 2001; 104(407):17-26. PubMed ID: 11229654
[TBL] [Abstract][Full Text] [Related]
2. Does hydrocortisone modify the in vitro susceptibility of Aspergillus fumigatus to itraconazole and amphotericin B?
Ramondenc I; Pinel C; Ambroise-Thomas P; Grillot R
Med Mycol; 1998 Apr; 36(2):69-73. PubMed ID: 9776816
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
Chen J; Li H; Li R; Bu D; Wan Z
J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
[TBL] [Abstract][Full Text] [Related]
4. Rapid quantification of itraconazole-resistant Aspergillus fumigatus in air.
Vanhee LM; Perman D; Nelis HJ; Coenye T
J Microbiol Methods; 2010 May; 81(2):197-9. PubMed ID: 20193715
[TBL] [Abstract][Full Text] [Related]
5. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
6. Sterol composition of itraconazole-resistant and itraconazole-susceptible isolates of Aspergillus fumigatus.
Dannaoui E; Persat F; Borel E; Piens MA; Picot S
Can J Microbiol; 2001 Aug; 47(8):706-10. PubMed ID: 11575496
[TBL] [Abstract][Full Text] [Related]
7. Rapid method for testing the susceptibility of Aspergillus fumigatus to amphotericin B, itraconazole, voriconazole and posaconazole by assessment of oxygen consumption.
Araujo R; Coutinho I; Espinel-Ingroff A
J Antimicrob Chemother; 2008 Dec; 62(6):1277-80. PubMed ID: 18824456
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone increases susceptibility of Aspergillus fumigatus to hydrogen peroxide via down-regulation of Afyap1 gene expression in vitro.
Xu H; Li LJ; Wan Z; Li RY; Liu W
Chin Med J (Engl); 2011 Nov; 124(22):3773-7. PubMed ID: 22340240
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance in Aspergillus fumigatus.
Warris A; Weemaes CM; Verweij PE
N Engl J Med; 2002 Dec; 347(26):2173-4. PubMed ID: 12501236
[No Abstract] [Full Text] [Related]
10. Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Guinea J; Peláez T; Alcalá L; Bouza E
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):273-6. PubMed ID: 17141455
[TBL] [Abstract][Full Text] [Related]
11. In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance.
da Silva Ferreira ME; Capellaro JL; dos Reis Marques E; Malavazi I; Perlin D; Park S; Anderson JB; Colombo AL; Arthington-Skaggs BA; Goldman MH; Goldman GH
Antimicrob Agents Chemother; 2004 Nov; 48(11):4405-13. PubMed ID: 15504870
[TBL] [Abstract][Full Text] [Related]
12. Generic substitution of itraconazole resulting in sub-therapeutic levels and resistance.
Pasqualotto AC; Denning DW
Int J Antimicrob Agents; 2007 Jul; 30(1):93-4. PubMed ID: 17412566
[No Abstract] [Full Text] [Related]
13. Interaction of local anaesthetics with other antifungal agents against pathogenic Aspergillus.
Rodrigues AG; Araujo R; Pina-Vaz C
Int J Antimicrob Agents; 2006 Apr; 27(4):339-43. PubMed ID: 16527460
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents.
Manavathu EK; Cutright J; Chandrasekar PH
J Clin Microbiol; 1999 Mar; 37(3):858-61. PubMed ID: 9986876
[TBL] [Abstract][Full Text] [Related]
15. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
Paterson PJ; Seaton S; Prentice HG; Kibbler CC
J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
[TBL] [Abstract][Full Text] [Related]
16. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
Manavathu EK; Cutright JL; Chandrasekar PH
Antimicrob Agents Chemother; 2005 Jan; 49(1):428-30. PubMed ID: 15616327
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Guinea J; Peláez T; Alcalá L; Bouza E
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):53-5. PubMed ID: 16650953
[TBL] [Abstract][Full Text] [Related]
19. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.
Denning DW; Radford SA; Oakley KL; Hall L; Johnson EM; Warnock DW
J Antimicrob Chemother; 1997 Sep; 40(3):401-14. PubMed ID: 9338494
[TBL] [Abstract][Full Text] [Related]
20. Serotonin (5-HT) enhances the activity of amphotericin B against Aspergillus fumigatus in vitro.
Heller I; Leitner S; Dierich MP; Lass-Flörl C
Int J Antimicrob Agents; 2004 Oct; 24(4):401-4. PubMed ID: 15380269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
